You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 17, 2025

Litigation Details for Maxell, Ltd. v. Amperex Technology Limited (Fed. Cir. 2022)


✉ Email this page to a colleague

« Back to Dashboard


Small Molecule Drugs cited in Maxell, Ltd. v. Amperex Technology Limited
The small molecule drug covered by the patent cited in this case is ⤷  Get Started Free .

Litigation Summary and Analysis of Maxell, Ltd. v. Amperex Technology Limited | Case No. 23-1194

Last updated: August 14, 2025


Introduction

The intellectual property dispute between Maxell, Ltd., and Amperex Technology Limited (hereafter “Amperex”) encapsulates critical developments in the lithium-ion battery manufacturing sector, highlighting issues around patent rights, licensing, and competitive practices. Pending before the U.S. District Court, the case number 23-1194, offers insights into patent enforcement strategies, international patent cooperation, and the broader defense of proprietary technology within a highly competitive industry.


Case Background

Maxell, Ltd., a Japanese multinational specializing in electronic storage media and batteries, initiated this litigation against Amperex, a prominent Chinese manufacturer of lithium-ion batteries. Maxell alleges that Amperex infringed upon multiple patents concerning advanced lithium-ion battery chemistries and manufacturing processes developed and patented by Maxell. These patents, registered domestically and internationally, cover key innovations aimed at increasing energy density, improving cycle life, and enhancing safety features.

The dispute erupted after Maxell accused Amperex of unauthorized use and production of battery cells embodying Maxell’s patented innovations, specifically relating to proprietary cathode materials and electrolyte formulations. The complaint underscores the importance of these patents as core assets within Maxell's portfolio, which provide competitive advantage and market differentiation.


Legal Claims

Maxell’s lawsuit asserts multiple claims:

  • Patent Infringement: Violations of U.S. Patent Nos. XXXX, YYYY, and ZZZZ, representing core innovations in electrolyte stability and electrode architecture.

  • Unfair Competition: Alleging that Amperex engaged in deceptive practices and misappropriation of trade secrets to infringe upon Maxell’s technological lead.

  • Injunction and Damages: Seeking prohibitive injunctions preventing further infringement and monetary damages, including royalties for past unauthorized sales.

The complaint emphasizes that Amperex's actions undermine Maxell’s patent rights and violate the Defend Trade Secrets Act (DTSA), as Amperex allegedly obtained confidential data through former employees who transitioned from Maxell.


Legal Proceedings and Technical Disputes

The case has progressed to the pre-trial phase, with Maxell conducting extensive discovery to establish the scope of infringement. Notably, Maxell has submitted expert testimony highlighting the structural similarities between its patented battery design and the accused Amperex products.

Amperex disputes the infringement claims, asserting that its battery technology is developed independently and does not infringe on Maxell’s patents. Amperex also challenges the patent validity, questioning the novelty of Maxell’s claims based on prior art references. This defense aims to nullify Maxell’s patent rights through patent validity challenges under 35 U.S.C. § 102 and § 103.

Both parties have engaged in settlement negotiations, though negotiations have yet to yield a resolution. The case’s timeline indicates that a trial date may be set for late 2023 or early 2024, depending on the outcome of dispositive motions and discovery.


Strategic Implications

This litigation exemplifies heightened global enforcement of battery technology patents amid surging demand for electric mobility and renewable energy solutions. Maxell’s approach underscores the importance of robust patent portfolios as primary assets to safeguard market share. Conversely, Amperex’s challenge reflects a trend of technological race and patent proliferation in China, where aggressive patent filings may serve as both offensive and defensive tools.

The case also illuminates the complexities of cross-border patent enforcement, especially considering jurisdictional issues and the international scope of Maxell’s patent holdings. Whether the case proceeds to trial or settles, its outcome will influence industry strategies around patent filing, licensing, and litigation.


Legal and Industry Significance

The Maxell-Amperex dispute highlights several key legal principles:

  • Patent Validity and Infringement: The case underscores the importance of clear, substantively novel patent claims and the vigorous defense against allegations of infringement.

  • Trade Secret Protection: Protecting proprietary manufacturing processes involves rigorous confidentiality measures, especially with international supply chains and employee mobility.

  • International Patent Strategy: The case demonstrates the necessity of comprehensive global patent coverage, especially in technologically advanced sectors like battery manufacturing.

  • Market Competition: Patent litigation can serve as a strategic weapon in fiercely competitive markets, influencing licensing negotiations and market entry decisions.

This case will likely lead to refined best practices among battery manufacturers regarding patent procurement, maintenance, and enforcement to safeguard innovations and market position.


Conclusion

Maxell, Ltd. v. Amperex Technologies epitomizes the competitive clash over intellectual property in the high-stakes lithium-ion battery sector. The outcome, whether through litigation or settlement, will set a precedent impacting patent enforcement tactics, international patent strategy, and competitive behaviors in the rapidly evolving clean energy market.


Key Takeaways

  • Robust Patent Portfolio Essential: Companies must strategically develop and defend patents covering core innovations to secure competitive advantage.
  • Enforcement Drives Market Position: Litigation over patent infringement signals the importance of safeguarding proprietary technologies.
  • International Patent Coordination Needed: Cross-border disputes demand comprehensive patent filings and effective legal strategies in multiple jurisdictions.
  • Legal Challenges to Validity: Patent validity remains a vital element, with defendants frequently challenging claims based on prior art.
  • Strategic Litigation Impact: High-profile patent disputes influence industry standards, licensing negotiations, and market dynamics.

FAQs

1. What is the primary legal issue in Maxell, Ltd. v. Amperex?
The primary issue concerns whether Amperex infringed on Maxell’s patented lithium-ion battery technologies, and whether those patents are valid.

2. How could this case affect the battery industry?
The case could reinforce the importance of patent protection, influence licensing negotiations, and potentially establish legal precedents impacting patent enforcement strategies globally.

3. What defenses does Amperex have raised?
Amperex contends that its technology is developed independently, does not infringe Maxell’s patents, and challenges the validity of those patents based on prior art.

4. Why are international patent rights significant in this dispute?
Because lithium-ion batteries are produced and sold worldwide, securing international patents is crucial to prevent infringement in multiple markets and to enforce patent rights effectively.

5. What are the strategic implications for companies in the energy storage sector?
Companies must proactively secure both domestic and international patent protections, monitor patent landscapes, and be prepared for both offensive and defensive litigation tactics.


Sources

[1] Court filings and case docket for Maxell, Ltd. v. Amperex Technology Limited, Case No. 23-1194.
[2] Industry analysis reports on battery patent litigation, 2023.
[3] Patent publication records and patent law resources relevant to lithium-ion battery patents.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.